Revolutionizing Assistive Tech: Myant and Coapt's Innovative Partnership Unveiled
In an exciting development for the assistive technology sector, Myant Corp., known for its pioneering advancements in textile computing for healthcare, has announced a collaboration with Coapt, a leading player in neural interface technology. This partnership aims to innovate and transform the landscape of assistive technology, particularly focusing on textile-based electromyography (EMG) interfaces. By combining their strengths, the two companies hope to enhance how prosthetic limbs and related therapeutic devices interact seamlessly with the human body.
The collaboration is set to leverage Coapt's state-of-the-art EMG intent decoder control systems along with Myant's advanced textile technologies. Together, they aim to create products that provide users with unparalleled comfort, precision, and control when utilizing assistive devices such as prosthetic limbs. This innovative approach is expected to not only enhance the functionality of these devices but also open new avenues for therapies that can address phantom limb pain and biofeedback-based solutions.
Tony Chahine, CEO of Myant, expressed enthusiasm about the partnership, stating, "Myant and Coapt share a vision of improving quality of life through seamless integration between technology and the human body." This goal underscores the companies' commitment to pushing the boundaries of what assistive devices can accomplish in terms of therapeutic outcomes and user satisfaction.
As part of their roadmap for future innovation, Myant and Coapt are also exploring applications of virtual and augmented reality in medical therapies. This exploration will include funded research and clinical trials to assess the broader implications of their technologies for patients on a global scale.
Blair Lock, CEO of Coapt, remarked on the potential impact of their collaboration, saying, "Together, Coapt and Myant are creating a future where assistive technology not only helps people regain function but also improves their overall comfort and autonomy." This statement encapsulates the ethos of the partnership—merging high-tech solutions with a strong focus on enhancing the user experience.
Myant is set to showcase its innovations at the Consumer Electronics Show (CES) from January 7-10, 2024, in Las Vegas. This event will be a platform for live demonstrations alongside Coapt, as both companies aim to accelerate the adoption of next-generation assistive technologies within the healthcare community.
Myant is on a mission to enable and elevate quality living for all people. By leveraging cutting-edge advancements in AI, medicine, and sophisticated materials, Myant seeks to provide enhanced health, safety, connection, and peace of mind across all life stages. The company is at the forefront of a new era, introducing AI-powered textile interfaces designed to function as a connected second skin. This innovation is poised to transform how individuals interact with digital spaces, improving everyday life experiences from infancy through elderhood.
In 2024, Myant expanded its presence into the European market and appointed renowned AI scientist Dr. Xin Gao as its Chief AI Officer, further enhancing its capabilities in the field.
For more in-depth information about Myant and its offerings, visit www.myant.ca.
Coapt, LLC is a Chicago-based private company with a research subsidiary, Liberating Technologies, Inc., located in Boston. Established in 2012, Coapt has rapidly emerged as a leader in the field of myoelectric, machine-learning prosthesis control systems. Their flagship product, Complete Control, is an FDA Class II-cleared technology that allows seamless control of advanced prosthetic devices. This innovative system utilizes clinically proven artificial intelligence to adapt to individual user patterns, making it compatible with over 450 unique prosthetic configurations.
For more about Coapt's groundbreaking work, visit https://coaptengineering.com/.
Textile Computing™ involves the integration of sensors and actuators into everyday fabrics, creating interfaces that can continuously sense and respond to human interactions. This revolutionary approach aims to empower individuals to enhance their capabilities, manage health proactively, and foster meaningful connections with their surroundings.
As these two companies embark on this groundbreaking venture, the future of assistive technology looks brighter than ever. The integration of advanced textile technologies with neural interface systems represents a significant leap forward, promising enhanced quality of life for those who rely on assistive devices.
The collaboration is set to leverage Coapt's state-of-the-art EMG intent decoder control systems along with Myant's advanced textile technologies. Together, they aim to create products that provide users with unparalleled comfort, precision, and control when utilizing assistive devices such as prosthetic limbs. This innovative approach is expected to not only enhance the functionality of these devices but also open new avenues for therapies that can address phantom limb pain and biofeedback-based solutions.
Tony Chahine, CEO of Myant, expressed enthusiasm about the partnership, stating, "Myant and Coapt share a vision of improving quality of life through seamless integration between technology and the human body." This goal underscores the companies' commitment to pushing the boundaries of what assistive devices can accomplish in terms of therapeutic outcomes and user satisfaction.
As part of their roadmap for future innovation, Myant and Coapt are also exploring applications of virtual and augmented reality in medical therapies. This exploration will include funded research and clinical trials to assess the broader implications of their technologies for patients on a global scale.
Blair Lock, CEO of Coapt, remarked on the potential impact of their collaboration, saying, "Together, Coapt and Myant are creating a future where assistive technology not only helps people regain function but also improves their overall comfort and autonomy." This statement encapsulates the ethos of the partnership—merging high-tech solutions with a strong focus on enhancing the user experience.
Myant is set to showcase its innovations at the Consumer Electronics Show (CES) from January 7-10, 2024, in Las Vegas. This event will be a platform for live demonstrations alongside Coapt, as both companies aim to accelerate the adoption of next-generation assistive technologies within the healthcare community.
About Myant
Myant is on a mission to enable and elevate quality living for all people. By leveraging cutting-edge advancements in AI, medicine, and sophisticated materials, Myant seeks to provide enhanced health, safety, connection, and peace of mind across all life stages. The company is at the forefront of a new era, introducing AI-powered textile interfaces designed to function as a connected second skin. This innovation is poised to transform how individuals interact with digital spaces, improving everyday life experiences from infancy through elderhood.
In 2024, Myant expanded its presence into the European market and appointed renowned AI scientist Dr. Xin Gao as its Chief AI Officer, further enhancing its capabilities in the field.
For more in-depth information about Myant and its offerings, visit www.myant.ca.
About Coapt
Coapt, LLC is a Chicago-based private company with a research subsidiary, Liberating Technologies, Inc., located in Boston. Established in 2012, Coapt has rapidly emerged as a leader in the field of myoelectric, machine-learning prosthesis control systems. Their flagship product, Complete Control, is an FDA Class II-cleared technology that allows seamless control of advanced prosthetic devices. This innovative system utilizes clinically proven artificial intelligence to adapt to individual user patterns, making it compatible with over 450 unique prosthetic configurations.
For more about Coapt's groundbreaking work, visit https://coaptengineering.com/.
About Textile Computing™
Textile Computing™ involves the integration of sensors and actuators into everyday fabrics, creating interfaces that can continuously sense and respond to human interactions. This revolutionary approach aims to empower individuals to enhance their capabilities, manage health proactively, and foster meaningful connections with their surroundings.
As these two companies embark on this groundbreaking venture, the future of assistive technology looks brighter than ever. The integration of advanced textile technologies with neural interface systems represents a significant leap forward, promising enhanced quality of life for those who rely on assistive devices.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.